Serum leptin level as an indicator to predict the clinical efficacy of troglitazone in patients with type 2 diabetes mellitus.

@article{Maruyama2001SerumLL,
  title={Serum leptin level as an indicator to predict the clinical efficacy of troglitazone in patients with type 2 diabetes mellitus.},
  author={Satoko Maruyama and Katsuyuki Yanagisawa and R. Kanamuro and Shinichi Teno and Yasuhiko Iwamoto},
  journal={Diabetes research and clinical practice},
  year={2001},
  volume={53 3},
  pages={161-4}
}
Troglitazone is effective in approximately 50% in patients with type 2 diabetes (NIDDM). In this study, we investigated the relations between serum leptin levels and clinical efficacy of troglitazone. Forty-five type 2 diabetic patients (23 men and 22 women) from our outpatient clinic were treated with troglitazone 400 mg daily for 12 weeks. Fasting plasma… CONTINUE READING